Dyne Therapeutics Inc (DYN)

EBITDA Growth

-57.27%

Quarterly · Period ending:

DYN logo

DYN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-57.27%
DYN Quarterly EBITDA YoY % (-46.79% → -57.27%)
High-resolution chart · PNG

DYN ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dyne Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-57.2656%
-1.0822%
-13.623%
-8.1986%
-70.4094%
-75.9941%
-34.5008%
-61.7407%
-0.3599%
-49.0874%
-66.6683%
-45.8451%
-24.3558%
-24.5094%
22.7466%
3.152%
-74.5237%
-41.2195%
-81.4638%
-210.8483%
-241.5661%
-224.2089%
-439.281%
-136.0437%
-269.7704%
-226.4881%
-740.367%
126.2626%
120.9256%
281.3411%
185.4902%
-68.4713%
-362.963%
2,043.75%
-288.8889%
245.0549%
9,550%
-79.4872%
650%
-36.8056%
81.8182%
7,900%
-98.1443%
27.4336%
98.9087%
-103.3333%
157.126%
71.2121%
-12,500%
-85.1485%
-600.885%
-56.5789%
-103.5586%
-18.5484%
8,575%
24.5902%
158.3912%
-15.6463%
-101.6064%
-68.7179%
-431.8966%
100%
130.5556%
5.1213%
-46.789%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.